Page 219 - Demo

General discussion and future perspectives217820. Giardino G, Cirillo E, Maio F, et al. Gastrointestinal involvement in patients affected with 22q11.2 deletion syndrome. Scandinavian Journal of Gastroenterology. 2014/03/01 2014;49(3):274-279. doi:10.3109/00365521.2013.85581421. van Duin EDA, Vaessen T, Kasanova Z, et al. Lower cortisol levels and attenuated cortisol reactivity to daily-life stressors in adults with 22q11.2 deletion syndrome. Psychoneuroendocrinology. Aug 2019;106:85-94. doi:10.1016/j.psyneuen.2019.03.02322. Cohen S, Janicki-Deverts D, Miller GE. Psychological Stress and Disease. JAMA. 2007;298(14):1685-1687. doi:10.1001/jama.298.14.168523. Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiol Stress. Dec 2017;7:124-136. doi:10.1016/j.ynstr.2017.03.00124. Jayakody DMP, Almeida OP, Speelman CP, et al. Association between speech and highfrequency hearing loss and depression, anxiety and stress in older adults. Maturitas. Apr 2018;110:86-91. doi:10.1016/j.maturitas.2018.02.00225. Chia EM, Wang JJ, Rochtchina E, Cumming RR, Newall P, Mitchell P. Hearing impairment and health-related quality of life: the Blue Mountains Hearing Study. Ear Hear. Apr 2007;28(2):187-95. doi:10.1097/AUD.0b013e31803126b626. van Splunder J, Stilma JS, Bernsen RM, Evenhuis HM. Prevalence of visual impairment in adults with intellectual disabilities in the Netherlands: cross-sectional study. Eye (Lond). Sep 2006;20(9):1004-10. doi:10.1038/sj.eye.670205927. Cohen JL, Crowley TB, McGinn DE, et al. 22q and two: 22q11.2 deletion syndrome and coexisting conditions. Am J Med Genet A. Oct 2018;176(10):2203-2214. doi:10.1002/ajmg.a.4049428. Svae GB, Blixt L, Søndenaa E. Personal and sexual boundaries: the experiences of people with intellectual disabilities. BMC Public Health. Sep 19 2022;22(1):1773. doi:10.1186/s12889-022-14181-x29. Moonen X, Festen D, Bakker-van Gijsel E, Vervoort-Schel J. A Dutch Perspective on Two Health Related Issues Regarding Children and Adolescents with Intellectual Disabilities. Int J Environ Res Public Health. Sep 16 2022;19(18)doi:10.3390/ijerph19181169830. Vorstman JA, Breetvelt EJ, Duijff SN, et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. JAMA Psychiatry. Apr 2015;72(4):377-85. doi:10.1001/jamapsychiatry.2014.267131. Scariati E, Schaer M, Richiardi J, et al. Identifying 22q11.2 deletion syndrome and psychosis using resting-state connectivity patterns. Brain Topogr. Nov 2014;27(6):808-21. doi:10.1007/s10548-014-0356-832. Tang SX, Moberg PJ, Yi JJ, et al. Olfactory deficits and psychosis-spectrum symptomsin 22q11.2 deletion syndrome. Schizophr Res. Dec 2018;202:113-119. doi:10.1016/j.schres.2018.07.01233. FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource. Food and Drug Administration (US)National Institutes of Health (US); 2016.34. Moss HE. Retinal Vascular Changes are a Marker for Cerebral Vascular Diseases. Curr Neurol Neurosci Rep. Jul 2015;15(7):40. doi:10.1007/s11910-015-0561-135. Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat. Apr 2005;206(4):319-48. doi:10.1111/j.1469-7580.2005.00395.x36. Appaji A, Nagendra B, Chako DM, et al. Retinal vascular abnormalities in schizophrenia and bipolar disorder: A window to the brain. Bipolar Disord. Nov 2019;21(7):634-641. doi:10.1111/bdi.1277937. Wu H, Wang C, Chen C, et al. Association between Retinal Vascular Geometric Changes and Cognitive Impairment: A Systematic Review and Meta-Analysis. J Clin Neurol. Jan 2020;16(1):19-28. doi:10.3988/jcn.2020.16.1.1938. Coppola G, Di Renzo A, Ziccardi L, et al. Optical Coherence Tomography in Alzheimer’s Disease: A Meta-Analysis. PLoS One. 2015;10(8):e0134750. doi:10.1371/journal.pone.0134750